- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00360919
Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion
Study Overview
Detailed Description
Cheese is one of the most commonly craved foods, suggesting the possibility of opiate activity, as has been demonstrated with other craved foods, particularly chocolate. Like other dairy products, cheese contains casein, which is the major protein in cow's milk. This is unlike human milk, in which the primary protein is whey. Casein includes αs1-, αs2-, β- , and κ-casein, with αs1 and β forms predominating. Human and bovine casein molecules are cleaved during digestion to release opioid peptides that are believed to have biological properties relevant to infant physiology and behavior. Specifically, β-casein is cleaved to form β-casomorphins. Like other opiate agonists, β-casomorphins prolong gastrointestinal transit time and have an antidiarrheal effect.
Casomorphin receptor binding has been demonstrated in opiate receptor assays and bioassays. Duodenal aspirates from human volunteers given cow's milk have demonstrated the presence of several casomorphins, particularly β-casomorphin-7. Few studies have assessed the presence or action of casomorphins in humans. The ability of casein-derived opioid peptides to pass into the bloodstream is not well characterized, and is the subject of the present study.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington, DC, District of Columbia, United States, 20016-4131
- Physicians Committee for Responsible Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age greater than 18 years
- Male or female
- Either self-described as having a strong liking for cheese, or have been following a vegan diet for a least the previous six months.
Exclusion Criteria:
- Unstable medical status
- Physical condition affecting eating behavior, digestion, or intestinal absorption
- Dairy allergy or lactose intolerance
- Pregnancy
- History of severe mental illness
- Smoking during the past six months
- Alcohol consumption of more than two drinks per day
- History of substance abuse or dependency followed by any current use
- Inordinate fear of blood draws
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A
Cheese
|
On study day 1, approximately half of the participants will consume a breakfast of fruits and vegetables, whereas the other half of participants will consume a meal consisting of 9 oz. of cheese. Blood samples will be collected from participants immediately prior to consumption of the meals, and then again at regular intervals for up to 8 hours following the meals. At least 3 days later, participants will return for study Day 2. The participants will receive the second meal. Blood samples will then be collected immediately prior to consumption of the test meal and for up to 8 hours after the meal. |
|
Placebo Comparator: B
Fruits and vegetables
|
On study day 1, approximately half of the participants will consume a breakfast of fruits and vegetables, whereas the other half of participants will consume a meal consisting of 9 oz. of cheese. Blood samples will be collected from participants immediately prior to consumption of the meals, and then again at regular intervals for up to 8 hours following the meals. At least 3 days later, participants will return for study Day 2. The participants will receive the second meal. Blood samples will then be collected immediately prior to consumption of the test meal and for up to 8 hours after the meal. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
casomorphin quantification
Time Frame: Measurements will be collected on designated studys within 12-hour time frame
|
Measurements will be collected on designated studys within 12-hour time frame
|
Collaborators and Investigators
Investigators
- Principal Investigator: Neal Barnard, MD, Physicians Committee for Responsible Medicine
- Study Director: Hope R Ferdowsian, MD, MPH, Washington Center for Clinical Research
Publications and helpful links
General Publications
- Shah NP. Effects of milk-derived bioactives: an overview. Br J Nutr. 2000 Nov;84 Suppl 1:S3-10. doi: 10.1017/s000711450000218x.
- Meisel H, FitzGerald RJ. Opioid peptides encrypted in intact milk protein sequences. Br J Nutr. 2000 Nov;84 Suppl 1:S27-31. doi: 10.1017/s000711450000221x.
- Brantl V, Teschemacher H, Blasig J, Henschen A, Lottspeich F. Opioid activities of beta-casomorphins. Life Sci. 1981 Apr 27;28(17):1903-9. doi: 10.1016/0024-3205(81)90297-6. No abstract available.
- Svedberg J, de Haas J, Leimenstoll G, Paul F, Teschemacher H. Demonstration of beta-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides. 1985 Sep-Oct;6(5):825-30. doi: 10.1016/0196-9781(85)90308-0.
- Drewnowski A, Krahn DD, Demitrack MA, Nairn K, Gosnell BA. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol Behav. 1992 Feb;51(2):371-9. doi: 10.1016/0031-9384(92)90155-u.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- WCCR-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Habits
-
University at BuffaloAmerican Heart AssociationCompletedFood Preferences | Food HabitsUnited States
-
University at BuffaloNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruiting
-
Pennington Biomedical Research CenterOhio State UniversityCompleted
-
Laval UniversityCompleted
-
Ecole Polytechnique Fédérale de LausanneCompleted
-
Centre for Fetal Programming, DenmarkHarvard School of Public Health (HSPH); Epidemic Health, Inc.Completed
-
Sophie RealeUniversity of Leeds; University of St AndrewsCompletedFood Habits | Acceptance Processes | Food, Snack
-
Tastermonial IncWCG clinical; Affordable Quality PharmaceuticalsCompletedFood HabitsUnited States
-
Karolinska InstitutetGöteborg University; University College Copenhagen; The Swedish Research Council...Completed
-
Karolinska InstitutetGöteborg University; The Swedish Research Council for Environment, Agricultural...Completed
Clinical Trials on cheese ingestion
-
Hospices Civils de LyonCompletedCardiometabolic RiskFrance
-
Anne Birgitte RabenUniversity of Aarhus; Arla FoodsCompleted
-
University of CopenhagenThe Danish Dairy Research Foundation, Denmark; National Dairy CouncilUnknown
-
Campus docent Sant Joan de Déu-Universitat de BarcelonaCompletedPulmonary Function | Nutrition, HealthySpain
-
Norwegian University of Life SciencesTineCompleted
-
University of AarhusInnovation Fund Denmark; Arla Foods; Team DenmarkCompletedProtein Metabolism
-
MeddocNorwegian School of Sport SciencesCompletedBone Health | Performance Enhancing Product UseNorway
-
University of CopenhagenDairy Farmers of Canada; The Danish Dairy Research Foundation, Denmark; Dairy... and other collaboratorsCompletedMetabolic SyndromeDenmark
-
MeddocTine; Norwegian University of Life SciencesCompletedOsteocalcin | Vitamin K Deficiency | Maintenance DoseNorway